GAMRIC 2026 Recap: Advancing the Fight Against Antimicrobial Resistance (AMR)
Explore insights from Medpace medical and operational experts on several key themes that emerged from GAMRIC 2026
What’s Next for ID&V? Clinical Development Trends from ESCMID Global 2026
Explore several of the key themes emerging from ESCMID Global 2026.
Key Takeaways from IDWeek 2025: AI, AMR Strategies, Next-Generation Anti-Viral Development Converging
IDWeek 2025 marked a pivotal moment in the evolution of infectious diseases (ID) research and pharmaceutical innovation. Beyond its traditional...
Clinical Strategy for UTI Drug Development
Clinical and Regulatory Considerations for Advancing Urinary Tract Infection (UTI) Drug Development in Women
Highlights from ESCMID Global 2025 and a Look Ahead into the Next Wave of Innovations
Explore insights from Medpace medical and operational experts as they identify key themes from ESCMID Global 2025.
Medpace’s Central Labs Expand Microbiology Services
Medpace is proud to announce the expansion of our microbiology capabilities at our state-of-the-art central laboratories in Cincinnati, Ohio, and...
Global Infectious Diseases & Vaccines Team – Clinical Operations Experts
In the following video series, Medpace experts across North America, Europe, Latin America, and Asia Pacific will explore how our ID&V team enhances the success…
Innovations in Infectious Diseases & Vaccines Clinical Development – Highlights from ESCMID Global 2024
Medpace infectious diseases and vaccines experts share key takeaways from ESCMID Global 2024 in Barcelona, Spain.
[Webinar] Women’s Health Month Panel
On May 28th, International Day of Action for Womens Health, the Medpace Women’s Health Leadership team is hosting a webinar panel entitled, “The Evolving Women's…
The Medpace Data Integrity Unit
Learn about our team comprised of highly trained microbiology specialists that provide ongoing evaluation and oversight of the microbiology aspects of infectious diseases studies.